Avalo Therapeutics, Inc. · NASDAQ:AVTX

FMR LLC reported a 11.50% stake in Avalo Therapeutics, Inc. (Schedule 13G)

Event Feb 27, 2026 · Filed Mar 6, 2026

FMR LLC reported a 11.50% stake in Avalo Therapeutics, Inc., 2,125,819 shares, as a passive investor on Feb 27, 2026. Filed Mar 6, 2026 (Schedule 13G).

Stake: 11.50%
Shares: 2,125,819
Intent: Passive
What changed: Crossed above 5%
Filed together: 2 holders

The filing in full

Holder	Stake	Shares
FMR LLC	11.50%	2,125,819
Abigail P. Johnson	11.50%	2,125,819

Source

View original at SEC

Related